Adalimumab vs Insulin Degludec

## Adalimumab vs Insulin Degludec: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Insulin Degludec**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Insulin Degludec — N/A.

## Chemical Properties

**Type**: Adalimumab — Antibody; Insulin Degludec — Protein.